Products

Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Herba Diclipterae Chinensis API
    • Einecs: 94279-99-9
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    854591

    Product Name Herba Diclipterae Chinensis Veterinary Grade API
    Plant Origin Dicliptera chinensis
    Appearance Powder or fine granules
    Color Brown to yellow-brown
    Odor Characteristic herbal odor
    Solubility Soluble in water and alcohol
    Main Uses Veterinary pharmaceuticals for tablets, injections, capsules, powders, granules, premix, solutions
    Active Ingredients Flavonoids, alkaloids, saponins
    Purity Typically ≥98%
    Storage Conditions Store in cool, dry place, protected from light
    Shelf Life 24 to 36 months when properly stored
    Moisture Content <5%
    Microbial Limit Complies with veterinary pharmacopeia standards
    Packing Sealed bags or drums
    Country Of Origin China

    As an accredited Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed 25kg fiber drum with double-layer polyethylene inner bags, clearly labeled "Herba Diclipterae Chinensis Veterinary Grade API" for pharmaceutical use.
    Shipping **Shipping Description:** Herba Diclipterae Chinensis Veterinary Grade API is securely packaged in fiber drums or double-sealed bags to ensure quality and safety. Shipped via air, sea, or express courier, with temperature and moisture controls as required. All shipments include appropriate documentation, compliant with international regulations for pharmaceutical ingredients.
    Storage Store Herba Diclipterae Chinensis Veterinary Grade API in a tightly sealed container, protected from light and moisture. Keep in a cool, dry, and well-ventilated area, ideally at temperatures below 25°C. Ensure the storage area is free from contamination and out of reach of unauthorized personnel. Avoid exposure to direct sunlight, heat sources, and incompatible substances.
    Application of Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Herba Diclipterae Chinensis extract offers targeted veterinary pharmaceutical applications, providing manufacturers with a reliable API source for regulated animal health products. Our plant-derived material supports strict production protocols across the veterinary field, and is processed according to industry-specific standards for use in tablets, injectables, oral solutions, dry premix, and feed additive forms. Below, we detail primary downstream application sectors with relevant regulatory, formulation, and processing parameters.

    1. Veterinary Antipyretic Tablet Formulation

    Veterinary pharmaceutical producers use this ingredient in compounded tablet lines focused on antipyretic and anti-inflammatory therapy for livestock. Powdered extract is integrated during granulation, where precise blending enhances reproducibility in active content per tablet. Consistent supply with controlled particle size and minimal moisture is prioritized to ensure downstream tablet compression and coating directly adhere to validated GMP release profiles.

    Industry compliance standards

    • Veterinary Pharmacopoeia of the People's Republic of China (2020 Edition)
    • EU GMP for Veterinary Medicinal Products
    • 21 CFR Part 211—Current Good Manufacturing Practice for Finished Pharmaceuticals (FDA, USA)
    • VICH GL43 Stability Testing of New Veterinary Drug Substances and Medicinal Products

    Typical usage ratio

    • 3–10% w/w as raw material in tablet blends; ratio adjusted to achieve 50–100mg API per standard dose depending on animal species and indication.

    Downstream process integration

    • Added during wet or dry granulation before tablet compression; direct blending for rapid-release formulas; post-blending before final packaging with in-process QC monitoring.

    Final product types

    • Antipyretic veterinary tablets for bovines, ovines, and swine
    • Multi-component compound animal health tablets
    • Sustained-release veterinary medicinal tablets
    • Pre-measured dose chewable tablets for companion animals

    2. Injectable Veterinary Solution Production

    Industrial-scale injectable solution manufacturing uses this API as an active pharmaceutical substance for parenteral therapeutics in veterinary settings, ensuring solubility and purity for intravenous and intramuscular administration. Our product undergoes additional filtration, sterilization pre-treatment, and batch QC to support stable and clear solution preparation conforming to stringent regulatory filing requirements for new veterinary injectable drugs.

    Industry compliance standards

    • US Pharmacopeia (USP) Veterinary Injectable Preparations
    • EU Directive 2001/82/EC relating to veterinary medicinal products
    • Chinese GMP—Requirements for Veterinary Injections (2020)
    • ISO 9001:2015 for Pharmaceutical Manufacturing

    Typical usage ratio

    • API concentration in injectable solutions: typically 1–10 mg/ml; concentration must comply with regulatory-approved formulations for specific indications or species.

    Downstream process integration

    • Dissolved post-filtration in aqueous solution under sterile conditions; included prior to final sterilization by filtration and aseptic filling; monitored for pH and isotonicity before vial sealing and labeling.

    Final product types

    • Veterinary injectable ampoules for livestock and poultry
    • Pre-filled veterinary injection syringes
    • Bulk sterile injectable concentrate for large-animal clinics
    • Multi-dose vials for farm use

    3. Veterinary Oral Capsule Manufacturing

    Producers of oral veterinary medicinal products incorporate the raw material as a central API in capsule forms targeting acute and chronic conditions. High-purity extract enables formulation of both hard and soft gelatin capsules. Downstream facilities rely on narrow batch-to-batch variation and low microbial load, facilitating reliable filling and capsule closure operations under validated cGMP protocols.

    Industry compliance standards

    • Veterinary Pharmacopoeia of China Reference Standards
    • European Medicines Agency (EMA) Quality Product Dossier
    • FDA CVM GFI #61 (Good Manufacturing Practices for Medicated Feed and Premix)
    • ISO 22716:2007 (Good Manufacturing Practices for Pharmaceuticals)

    Typical usage ratio

    • 10–40 mg per veterinary capsule—precise loading based on end-use animal weight class or treatment protocol, with adjustments documented in the master batch record.

    Downstream process integration

    • Weighing and blended directly into capsule blend matrix; loaded via capsule filling machines; subject to disintegration and dissolution QC during batch release.

    Final product types

    • Gastro-resistant capsules for canine and feline use
    • Standard veterinary capsules for equine administration
    • Combination therapy capsules for ruminants
    • Veterinary prescription-only medicinal capsules

    4. Feed Additive and Premix Blending

    Animal nutrition and feed mills introduce the plant-derived API to create functional feed additives and premixes aimed at disease prevention and health maintenance in livestock. Homogeneous incorporation is essential to meet label claim per kilogram finished feed, with manufacturers implementing rigorous mixing validation and post-mix sampling. Feed grade and veterinary API documentation ensure traceability from raw material batch through to finished compound feed shipment.

    Industry compliance standards

    • GB 13078-2017 Hygienic Standards for Feeds (China)
    • FAMI-QS European Feed Additives and Premixtures Quality System
    • FDA 21 CFR Part 589 (Animal Feed—Substances Prohibited From Use)
    • ISO 22000:2018 (Food Safety Management in Feed Production)

    Typical usage ratio

    • Premix formulation: 0.05–0.5% w/w in base carrier blend; final feed additive inclusion levels range between 50–400 mg/kg finished feed, based on approved national feed regulations and animal species.

    Downstream process integration

    • Combined into premix at the pre-mixing phase; blended into total ration during feed mill batch mixing; in-line QC with NIR or HPLC validation before bagging and dispatch.

    Final product types

    • Medicated complete feeds for sows, broodstock, and poultry
    • Concentrated feed premixes for ruminants and aquaculture
    • Veterinary-approved oral powder feed additives
    • Nutritional supplement blends for intensive livestock systems

    5. Veterinary Granule and Water-Soluble Powder Production

    Granule and powder formulation plants utilize this API in products requiring rapid dissolution or dispersion in water for oral veterinary dosing. Controlled particle size distribution and quick-release profiles are achieved through precision blending and granulation technologies. Material is validated for flowability, stability during storage, and ease of measuring for on-farm use, supporting convenient delivery routes and accurate dosing in animal health interventions.

    Industry compliance standards

    • Chinese Veterinary Drug GMP (2022 Edition)
    • APVMA (Australian Pesticides and Veterinary Medicines Authority) Compliance for Oral Powders
    • OIE (World Organisation for Animal Health) Feed Additive Listing Guidelines
    • SFDA Guidance for Veterinary Granules and Powders

    Typical usage ratio

    • 250–1000 mg API per 100 g sachet or pack; precise loadings set based on targeted animal size, daily intake, and treatment period—subject to country registration dossiers.

    Downstream process integration

    • API pre-mixed with excipients during high-shear granulation; drier and mill integration for powder fineness; batch quality confirmed with uniformity and moisture testing before final sachet, bag, or tub packing.

    Final product types

    • Single-dose veterinary antipyretic powders for farm use
    • Granule sachets for dilution in livestock drinking water
    • Medicated soluble powders for respiratory relief
    • Poultry and swine oral granule packs

    Free Quote

    Competitive Herba Diclipterae Chinensis Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Herba Diclipterae Chinensis Veterinary Grade API: A Closer Look at Its Role in Modern Animal Health

    Long Years of Experience Go into One Batch

    In manufacturing Herba Diclipterae Chinensis Veterinary Grade API, I’ve watched demand move with industry trends, feed formulas, and veterinary research. Over the last decade, producers and veterinarians have started paying more attention to plant-based actives, flock treatments, and animal welfare. Companies under pressure to limit antibiotic residues have searched for replacements that deliver results, don’t disrupt animal performance, and can be adapted to premixes, oral solutions, water-soluble powders, and capsules. Through all of this, Herba Diclipterae Chinensis, a botanical extract with a solid traditional background, has gained a special spot in animal health applications. As we’ve scaled up production, I’ve seen firsthand the technical hurdles behind each format—whether someone prepares a liquid injection or a pressed tablet.

    A Botanical Extract that Earns Its Keep in Feed and Veterinary Pharma

    We started investing in Herba Diclipterae Chinensis long before many others. This wasn’t because of its reputation alone, but from requests that kept coming in from big farms and animal health companies. They asked about clean, plant-derived APIs for specific livestock challenges. Our partners wanted to keep up with rising standards for residue limits—especially in markets where consumers push hard for transparency on livestock treatments. Every batch we produce begins at the raw herb level, chosen with attention to active constituent profiles. These aren’t abstract quality standards that get slapped on a spec sheet; they translate to consistency in animal response, improved solubility for formulations, and smoother integration into automated production lines.

    Model Strengths: From Powders to Injections—Real Differences Matter

    We manufacture Herba Diclipterae Chinensis API in powder, granular, premix, tablet, capsule, injectable, and oral solution forms. Each has its strengths. Powders work most easily into daily rations or direct-dose regimens on large poultry or swine operations. Premixes help feed mills reach micro-dose accuracy and keep dosing steady throughout the batch. Solutions serve veterinarians handling acute outbreaks — dosing can be precise, and absorption tends toward the fast side. Injections stand apart for veterinarians who need immediate action or face outbreaks where enteral absorption won’t cut it. Where tablets and capsules fit best comes from areas that need strict dosing, stability across seasons, and products that survive long shelves in remote clinics.

    Pharmaceutical production means more than mixing and packaging—tablets and capsules draw on controlled compression, binding, humidity, and extract standardization. Our team doesn’t separate extraction from downstream formulating. I’ve spent time on the factory floor watching parameters such as pH, particle size, and moisture content get adjusted for every order. The lessons are clear: even a change in particle dimensions can shift the way an API binds with other excipients—a detail that matters for dissolution in the animal’s gut.

    Regulations Keep Us Honest—and Accountable to Animal Health

    Veterinary APIs face growing scrutiny, both in export and domestic markets. The plant-based sector is not immune. We document the entire Herba Diclipterae Chinensis process for traceability—samples, analytical data, and validation, batch by batch. Years ago, less attention fell on herb content standardization, but modern animal pharma needs every lot to match precisely, regardless of climate, crop yield, or region of harvest. Failure in batch-to-batch consistency triggers delays, throwaway batches, or regulatory investigations. Our customers expect more. Feed integrators have run multiple trials to measure performance outcomes; results turn on a stable and predictable API, not just the lab result but the lived experience in the field.

    Ensuring API quality relies on validated extraction processes. For Herba Diclipterae Chinensis, the active molecule group brings its own set of extraction and purification headaches. Season affects plant actives, so every harvest translates to a slightly different chemical profile. We respond by monitoring extraction yields, using chromatography and marker compounds to confirm actives. On our side, we’ve learned to flag every outlier early in the process, cutting off potential costly recalls or product complaints before these reach the end customer. Controlled humidity, temperature, and particulate filtration all shape the final API, demanding vigilance and quick troubleshooting. Our regulatory team sits close to production—audits, not just paperwork, provide the backbone for compliant production.

    A Field-Driven View of Specifications and Performance

    Our specifications come from repeated requests and side-by-side user trials. Large farms compare our API across brands, looking for animal recovery rates, feed efficiency, and cost benefits over antibiotic regimens. Animal health depends on how well the API fits specific health challenges—there’s no blank check for any plant extract. Our process pays close attention to active content, solubility, particle size, and stability under real farm conditions. Product stability through varying humidity and temperature has beaten most of our competition, especially in hot, high-moisture regions. We deliver for operations where cold chain and perfect storage can't be guaranteed year-round.

    Delivering consistent, process-ready powder or granule forms turns into a real technical challenge during the summer monsoon or dry winter seasons. The warehouse team checks every outgoing batch for not just lab results but also the physical behavior: caking, clumping, dusting, and flow are logged and compared over time. Performance in the field gets fed back into the plant, adjusting upstream processing if packaging or distribution shows weak points. Our advantages stem from decades spent working with customers—not abstract sales promises, but direct bench-to-farm accountability.

    What Sets Our API Apart from Other Plant-Based Offers

    Some APIs on the market tout high actives content, but real performance depends on more than a single lab reading. I’ve seen other companies send out material with fluctuating plant marker ratios—fine for supplements, but unacceptable when a veterinarian needs repeatable therapeutic results. Every gram of our Herba Diclipterae Chinensis comes with a real-time activity and stability score, not just theoretical claims. In our facility, we test for both the primary and secondary actives, adjusting extraction and processing to guard against seasonal swings in the raw herb.

    A lot of competitors focus on high-extract yields, sometimes at the cost of thermal or solvent residues that can risk animal health or disrupt other ingredients in a premix. We run repeated solvent residue screens and invest in low-heat processing. The results mean peace of mind for our customers: no hidden breakdown products, less risk of feed rejection, and a lower chance of adverse events on the farm. Veterinarians and feed mills see the impact of lab values turning into field reliability. Instead of unexplained variation, our process closes the gap between what’s measured in a test tube and what’s delivered in a finished ration, injection, or tablet.

    Why Form and Format Matter: Production Realities on the Floor

    Tablets and capsules face totally different technical demands than powders or solutions. Tablet production absorbs a lot of know-how: the extract’s particle size, flow, and binding impact how tablets press, hold together, and release actives inside the animal. Our team runs dedicated lines for Herba Diclipterae Chinensis tablets, tuning each run for hardness, friability, and dissolving speed. Capsules attract specialty vet clients, especially for small animal or high-value livestock. Capsule fill and shell compatibility come under strict review—there’s no tolerance for variability.

    Premix and granule batches run on lines shared with other plant APIs, which creates cleanout and cross-contamination challenges. We schedule downtime to audit, test, and reset equipment, always making sure the Herba Diclipterae Chinensis content stays true to label claims. Not every company wants to spend labor and machine time this way, but this approach knocks down complaints and upholds our long-term reputation in the veterinary field.

    Solutions and injectables need clarity, pH control, and preservative screening. Our R&D group spends as much time testing long-term storage stability as they do on immediate-release performance, especially under shipping or warehouse stress. Some clients in tropical regions flag color, precipitation, or bottle compatibility; these seem like small complaints, but for a manufacturer, they show where further formulation work pays off. Problems flagged in one region prompt reviews for every market, closing the loop between production, lab, and livestock user.

    Meeting Industry and Client Demands Head-On

    The reality of every animal market is pressure from regulators, livestock buyers, and consumer groups. Our approach to Herba Diclipterae Chinensis has become less about just filling a product line, more about proving ourselves against a checklist handed down from farms and feed mills. Clients push for supplier transparency, full batch-trace, and open dialogue about quality issues. We open our plant to audits, trials, and occasional troubleshooting sessions with vet advisers. Combining direct feed-trial data with batch records lets us catch new field issues before they get out of hand.

    Many animal pharma producers under-deliver on plant-based APIs; their main goal is quick throughput, not responsive quality control. Maintaining trust means keeping technical staff available for feedback sessions, sample shipments, and visiting customer facilities. Our willingness to work with customers on new formats—adding small batch adjustments, quick-turn pilot runs, or custom specs—costs more, but brings stronger partnerships and fewer emergency recalls. These aren’t shortcuts for us; they build our role in responsible animal health solutions.

    Product Legacy, Reputation, and the Way Forward

    Raw material supply for Herba Diclipterae Chinensis changes year to year, driven by weather, grower practices, and demand from the human herbal industry. We work directly with trusted, contracted suppliers, routinely visiting fields and post-harvest storage. Harvest and drying method alter the first step in actives retention, and early mistakes multiply through extraction and processing. Our supply agreements include training, root cause analysis of poor yields, and investment in better handling or drying if problems appear at the grower level.

    Animal health clients want more security against raw material swings, so we spread sourcing across several regions to buffer against bad years. Our QA teams reject lots that miss actives benchmarks, even if they cost more up front. Every operator and batch chief in our plant knows these calls earn their keep on the customer side: one tainted batch ripples into lost feed contracts and regulatory headaches.

    Veterinary partners who’ve relied on our Herba Diclipterae Chinensis often reference performance data: consistent animal weight gain, rapid symptom drop-off, recovery rates, or customer satisfaction scores from their farms. Some customers start with us on one format and switch to others as their needs grow—moving from powders to solutions as their practice evolves. We view these transitions as signs of trust in both our API and our ability to support customers through the ups and downs of real-world livestock management.

    Facing Today’s and Tomorrow’s Challenges

    Every plant API manufacturer deals with questions beyond claims and brochures. Feed and veterinary medicine players want to talk about heavy metals, trace solvents, batch recalls, and compliance with fast-changing standards. We’ve shifted more resources into analytical verification, cross-checking our results with outside labs, answering any flagged complaints with speed and transparency. More regulators and buyers demand digital batch history, not just paper slips. We’ve updated our records with secure, accessible audit trails, reassuring buyers across the chain.

    There’s no ignoring rapid growth in specialty livestock—poultry, aquaculture, and even exotics—each with its own usage and stability challenges. Clients ask us daily about compatibility with vitamins, minerals, and other medications. Our technical team takes these field problems seriously, testing our Herba Diclipterae Chinensis in common feed mixes and with various excipients. Issues like caking with certain vitamins, loss of activity near acidic minerals, or incompatibility with fat supplements—these aren’t mysteries. We address them with targeted R&D and, when needed, sharing direct guidance with end users. Where partner feedback shows gaps, we tweak extraction or formulation, adapting faster than most competitors are willing.

    Improving Animal Health Without Compromise

    Talk about plant-based APIs is often laced with marketing, but at the ground level, benefits must show up both in the science and in the customer’s actual animal outcomes. Our Herba Diclipterae Chinensis comes from long-term technical investment, steady feedback from frontline users, and a belief that plant-based therapies can—and should—contribute to animal welfare without hidden compromises. We’re not blind to the pressures customers face: drug resistance, regulatory inspections, recalls for contaminants, and tight economic margins. Every improvement in our API costs time and effort, but the industry’s move away from cheap, low-grade actives is not about cost alone. It reflects a deeper push for safety, transparency, and repeatable value.

    Our position comes from the inside: running the extraction, troubleshooting batches, answering customer trials gone sideways, and keeping our ear to the realities of global livestock care. With Herba Diclipterae Chinensis, we strengthen not just a product, but a supply chain built for accountability, science, and the daily needs of veterinary and livestock professionals.

    Top